我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI，丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。它可以让您创建简单易行的服药时间表，并设置隐藏和个性化的提醒。

全部新闻 / 三月 2022

归档

✕

25 三月 2022

2268

Kidney dysfunction in people living with HIV

Kidney dysfunction in people living with HIV

Both the HIV virus and the antiretroviral drugs taken to treat it can cause kidney damage, but there are other risk factors at play. A twelve-year-long study in South Africa examined the relationship between kidney disease and mortality amongst people living with HIV. The ...

25 三月 2022

2452

HIV continues to hide in cytotoxic T-cell clones

HIV continues to hide in cytotoxic T-cell clones

Antiretroviral treatment (ART) is very effective at controlling HIV, to a point where it can no longer be passed on, but the virus never disappears completely - it is hiding in about one in every million immune cells. In particular, HIV hides in special cells known as ...

25 三月 2022

2234

Moderate strength training can help with peripheral neuropathy in PLHIV

Moderate strength training can help with peripheral neuropathy in PLHIV

Many people living with HIV, at some point, will experience chronic pain due to peripheral neuropathy. New research indicates that moderate strength training of the leg muscles may significantly improve the situation. The results of the study ‘Strength exercise for balance ...

25 三月 2022

2194

Men living with HIV twice as likely to experience certain cancers

Men living with HIV twice as likely to experience certain cancers

Researchers from Cleveland, Ohio, found that men living with HIV were almost twice as likely to also have cancer when compared to men who are HIV negative. The risk of developing a tumour also appears to increase significantly in the presence of high viral load. The analysis ...

21 三月 2022

2822

Moderna announces first trial participants have received the Trimer mRNA HIV vaccine

Moderna announces first trial participants have received the Trimer mRNA HIV vaccine

Moderna, a biotechnology and pharmaceutical company based in Massachusetts, have announced the launch of Phase I of clinical trials into their Trimer mRNA HIV vaccine (mRNA-1574). The first participants has now received their first dose of the mRNA-based vaccine. The ...

21 三月 2022

2427

For Life4me+ 2021 was all about “Respect my HIV”

For Life4me+ 2021 was all about “Respect my HIV”

For Life4me+, 2021 was a very busy year. Despite the fact that everyone had to learn to live in the reality of COVID-19, it was a year of scientific success in the field of HIV - after the stagnation of 2020. 2021 was a year of new information projects and conferences ...

21 三月 2022

1888

Asymptomatic tuberculosis more common in people living with HIV

Asymptomatic tuberculosis more common in people living with HIV

A study, conducted in South Africa, has found that the incidence of subclinical (asymptomatic) tuberculosis is higher in people living with HIV and similar to that of those with clinical tuberculosis (TB). The study was published in Healio Magazine. These findings have ...

14 三月 2022

2451

‘Dare to share care’ campaign launched to support HIV care in Ukraine

‘Dare to share care’ campaign launched to support HIV care in Ukraine

Europe is home to almost three million people living with HIV, with over 250,000 of those living in Ukraine. The invasion of Ukraine and the armed conflict have threatened the care for those quarter of a million people. The Young Investigators (YING) in partnership with ...

11 三月 2022

2155

Cabotegravir: Every other month dosing may carry viral load risks

Cabotegravir: Every other month dosing may carry viral load risks

Clinical trial researchers have found that people who received injectable cabotegravir (Vocabria) and rilpivirine (Rekambys) every other month maintained viral suppression just as well as those who received the drug monthly, but patients on the every other month dosing schedule ...

11 三月 2022

2146

Geographical modelling and HIV transmission

Geographical modelling and HIV transmission

Sexual interactions between people from different communities might explain why HIV prevention efforts targeting single communities weren’t as effective has expected. This is according to a study, published in eLife. Magus and his colleagues based their research on HIV ...

1 2